Skip to main content

. 1988 Dec;58(6):776–778. doi: 10.1038/bjc.1988.307

The killing effects of 4-S-cysteinylcatechol and analogues on human melanoma cells.

I Yamada ¹, S Seki ¹, S Ito ¹, O Matsubara ¹, S Suzuki ¹, T Kasuga ¹

PMCID: PMC2246856 PMID: 3146990

776

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chavin W., Jelonek E. J., Jr, Reed A. H., Binder L. R. Survival of mice receiving melanoma transplants is promoted by hydroquinone. Science. 1980 Apr 25;208(4442):408–410. doi: 10.1126/science.7367868. [DOI] [PubMed] [Google Scholar]
Fujita K., Ito S., Inoue S., Yamamoto Y., Takeuchi J., Shamoto M., Nagatsu T. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo. Cancer Res. 1980 Jul;40(7):2543–2546. [PubMed] [Google Scholar]
Graham D. G., Tiffany S. M., Vogel F. S. The toxicity of melanin precursors. J Invest Dermatol. 1978 Feb;70(2):113–116. doi: 10.1111/1523-1747.ep12541249. [DOI] [PubMed] [Google Scholar]
Ito S., Inoue S., Yamamoto Y., Fujita K. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds. J Med Chem. 1981 Jun;24(6):673–677. doi: 10.1021/jm00138a006. [DOI] [PubMed] [Google Scholar]
Ito S., Kato T., Ishikawa K., Kasuga T., Jimbow K. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. Biochem Pharmacol. 1987 Jun 15;36(12):2007–2011. doi: 10.1016/0006-2952(87)90501-6. [DOI] [PubMed] [Google Scholar]
Jimbow K., Obata H., Pathak M. A., Fitzpatrick T. B. Mechanism of depigmentation by hydroquinone. J Invest Dermatol. 1974 Apr;62(4):436–449. doi: 10.1111/1523-1747.ep12701679. [DOI] [PubMed] [Google Scholar]
Pawelek J. M. Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol. 1976 Apr;66(4):201–209. doi: 10.1111/1523-1747.ep12482134. [DOI] [PubMed] [Google Scholar]
Penney K. B., Smith C. J., Allen J. C. Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol. 1984 Apr;82(4):308–310. doi: 10.1111/1523-1747.ep12260588. [DOI] [PubMed] [Google Scholar]
Wick M. M., Byers L., Frei E., 3rd L-dopa: selective toxicity for melanoma cells in vitro. Science. 1977 Jul 29;197(4302):468–469. doi: 10.1126/science.877570. [DOI] [PubMed] [Google Scholar]
Wick M. M. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol. 1978 Aug;71(2):163–164. doi: 10.1111/1523-1747.ep12546959.1. [DOI] [PubMed] [Google Scholar]
Wick M. M. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res. 1980 May;40(5):1414–1418. [PubMed] [Google Scholar]

ACTIONS

RESOURCES